Mitsubishi UFJ Asset Management Co. Ltd. Acquires 102,127 Shares of CVS Health Corporation $CVS

Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in CVS Health Corporation (NYSE:CVS) by 4.2% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,518,593 shares of the pharmacy operator’s stock after purchasing an additional 102,127 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in CVS Health were worth $189,877,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. boosted its position in CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 142 shares during the period. Corundum Trust Company INC bought a new stake in shares of CVS Health in the 3rd quarter valued at about $29,000. Front Row Advisors LLC boosted its holdings in CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 371 shares during the period. Twin Peaks Wealth Advisors LLC purchased a new stake in CVS Health during the 2nd quarter valued at about $36,000. Finally, SOA Wealth Advisors LLC. grew its holdings in shares of CVS Health by 36.9% in the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 131 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. UBS Group restated an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. The Goldman Sachs Group raised their target price on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Wells Fargo & Company lowered their price target on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. JPMorgan Chase & Co. increased their price objective on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a report on Wednesday, December 17th. Finally, Evercore boosted their target price on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Nineteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.91.

CVS Health Stock Up 2.4%

Shares of NYSE:CVS opened at $77.99 on Friday. The firm has a market capitalization of $99.22 billion, a P/E ratio of 56.51, a P/E/G ratio of 0.80 and a beta of 0.50. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The stock has a 50 day moving average price of $78.35 and a 200-day moving average price of $77.02. CVS Health Corporation has a 52-week low of $58.35 and a 52-week high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.09. The company had revenue of $105.69 billion for the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The firm’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.